Close of Accelerated Bookbuild

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN QUANTUM PHARMA PLC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF QUANTUM PHARMA PLC.

20 October 2016

This announcement contains inside information

Quantum Pharma Plc

('Quantum', the 'Group' or the 'Company')

Close of accelerated bookbuild - successful fundraise of £15 million at 34p per share

Quantum Pharma plc (AIM: QP.) announces that, further to the announcement made earlier today entitled "Proposed Accelerated Bookbuild to raise up to £15 million", the accelerated bookbuild process has now closed. The accelerated bookbuild was successful and the Company has conditionally raised a total of £15 million, subject to the passing of certain resolutions by shareholders at a General Meeting. The Company will shortly announce the full details of the proposed Placing and post a circular to Shareholders containing these details and convening a General Meeting.

For further information: